생명과학회지 (Journal of Life Science)

  • 제21권1호
  • /
  • Pages.22-30
  • /
  • 2011
  • /
  • 1225-9918(pISSN)
  • /
  • 2287-3406(eISSN)
한국생명과학회 (Korean Society of Life Science)
권호 표지
DOI QR코드

DOI QR Code

인간 호중구의 세포사멸과 시토카인 분비에 대한 아포지방단백 A-I의 영향

Effects of Apolipoprotein A-I on Apoptosis and Cytokine Production in Human Neutrophils

  • 강형곤 (동아대학교 의료원 신경외과학교실) ;
  • 최재형 (동아대학교 의료원 신경외과학교실) ;
  • 허재택 (동아대학교 의료원 신경외과학교실)
  • Kang, Hyung-Kon (Department of Neurosurgery, College of Medicine, Donga-A University) ;
  • Choi, Jae-Hyung (Department of Neurosurgery, College of Medicine, Donga-A University) ;
  • Huh, Jae-Taeck (Department of Neurosurgery, College of Medicine, Donga-A University)
  • 투고 : 2010.08.31
  • 심사 : 2010.09.30
  • 발행 : 2011.01.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

아포지방단백 A-I (apoA-I)은 항염증 및 항산화 작용을 가지고 있는 것으로 알려져 있다. 본 논문에서는 인간 혈액의 호중구를 이용하여 in vitro 상태에서 세포사멸과 시토카인의 분비 과정에 미치는 apoA-I의 영향을 조사하였다. 인간 호중구에 apoA-I을 처리한 결과 세포사멸의 정도가 감소되었다. 또한, apoA-I을 함유하는 고밀도 지방단백(HDL)에 의하여도 세포사멸은 현저히 감소되었다. HDL이 결합하는 수용체인 scavenger 수용체 B-1에 대한 항체에 의하여도 세포사멸은 억제되었다. ApoA-I을 20 시간 처리한 세포의 배양액내 인터루킨-8, 인터페론-유도단백질 10(IP-10) 및 종양괴사인자-α의 분비가 현저히 증가하였다. 호중구에 인터페론 감마와 apoA-I을 동시 처리하였을 때 시토카인 중에서 IP-10과 종양괴사인자-$\alpha$의 분비가 단독으로 처리한 경우에 비해 현저히 증가되었다. 이러한 결과들은 인간 혈액 호중구에 apoA-I을 처리한 경우 호중구가 활성화되고 호중구의 세포사멸이 지연된다는 것을 제시하는 것으로 apoA-I이 호중구에 대하여 염증성 인자로 작용할 것으로 추정된다.

Apolipoprotein A-I (apoA-I) has anti-inflammatory and anti-oxidative properties. This study was designed to investigate whether apoA-I affects apoptosis and cytokine production of human blood neutrophils in an in vitro culture system. Spontaneous apoptosis of neutrophils was significantly delayed by apoA-I. In addition, high density lipoprotein containing apoA-I also delayed apoptosis of neutrophils. Apoptosis of neutrophils was inhibited by anti-scavenger receptor type B-I antibodies. The amounts of interleukin-8, interferon (IFN)-inducible protein 10 (IP-10), and tumor necrosis factor-$\alpha$ (TNF-$\alpha$) in the supernatants of cultured neutrophils treated with apoA-I were significantly increased. Combined treatment of neutrophils with IFN-$\gamma$ and apoA-I produced higher amounts of IP-10 and TNF-$\alpha$ than did treatment with IFN-$\gamma$ or apoA-I alone. The present study reveals that apoA-I activates neutrophils to produce cytokines and delays spontaneous apoptosis of neutrophils. These findings suggest that apoA-I, although a well-known negative acute-phase protein, has a pro-inflammatory effect in neutrophils.

키워드

참고문헌

  1. Barter, P. J. and K. A. Rye. 2006. The rationale for using apoA-I as a clinical marker of cardiovascular risk. J. Intern. Med. 259, 44-54. https://doi.org/10.1111/j.1365-2796.2006.01647.x
  2. Blackburn, W. D. Jr., J. G. Dohlman, Y. V. Venkatachalapathi, D. J. Pillion, W. J. Koopman, J. P. Segrest, and G. M. Anantharamaiah. 1991. Apolipoprotein A-I decreases neutrophil degranulation and superoxide production. J. Lipid Res. 32, 1911-1918.
  3. Brennan, M. L., M. M. Anderson, D. M. Shih, X. D. Qu, X. Wang, A. C. Mehta, L. L. Lim, W. Shi, S. L. Hazen, J. S. Jacob, J. R. Crowley, J. W. Heinecke, and A. J. Lusis. 2001. Increased atherosclerosis in myeloperoxidase-deficient mice. J. Clin. Invest. 107, 419-430. https://doi.org/10.1172/JCI8797
  4. Bruunsgaard, H., P. Skinhoj, A. N. Pedersen, M. Schroll, and B. K. Pedersen. 2000. Ageing, tumour necrosis $factor-{\alpha}$ $(TNF-{\alpha})$ and atherosclerosis. Clin. Exp. Immunol. 121, 255-260. https://doi.org/10.1046/j.1365-2249.2000.01281.x
  5. Burger, D. and J. M. Dayer. 2002. High-density lipoprotein- associated apolipoprotein A-I: the missing link between infection and chronic inflammation? Autoimmun. Rev. 1, 111-117. https://doi.org/10.1016/S1568-9972(01)00018-0
  6. Cassatella, M. A., I. Guasparri, M. Ceska, F. Bazzoni, and F. Rossi. 1993. $Interferon-{\gamma}$ inhibits interleukin-8 production by human polymorphonuclear leucocytes. Immunology 78, 177-184.
  7. Charo, I. F. and M. B. Taubman. 2004. Chemokines in the pathogenesis of vascular disease. Circ. Res. 95, 858-866. https://doi.org/10.1161/01.RES.0000146672.10582.17
  8. Farber, J. M. 1997. Mig and IP-10: CXC chemokines that target lymphocytes. J. Leukoc. Biol. 61, 246-257.
  9. Fidge, N. H. 1999. High density lipoprotein receptors, binding proteins, and ligands. J. Lipid Res. 40, 187-201.
  10. Furlaneto, C. J., F. P. Ribeiro, E. Hatanaka, G. M. Souza, M. A. Cassatella, and A. Campa. 2002. Apolipoproteins A-I and A-II downregulate neutrophil functions. Lipids 37, 925-928. https://doi.org/10.1007/s11745-002-0981-4
  11. Gardai, S. J., D. A. Hildeman, S. K. Frankel, B. B. Whitlock, S. C. Frasch, N. Borregaard, P. Marrack, D. L. Bratton, and P. M. Henson. 2004. Phosphorylation of Bax Ser184 by Akt regulates its activity and apoptosis in neutrophils. J. Biol. Chem. 279, 21085-21095. https://doi.org/10.1074/jbc.M400063200
  12. Gasperini, S., M. Marchi, F. Calzetti, C. Laudanna, L. Vicentini, H. Olsen, M. Murphy, F. Liao, J. Farber, and M. A. Cassatella. 1999. Gene expression and production of the monokine induced by IFN-gamma (MIG), IFN-inducible T cell alpha chemoattractant (I-TAC), and IFN-gamma-inducible protein-10 (IP-10) chemokines by human neutrophils. J. Immunol. 162, 4928-4937.
  13. Gerszten, R. E., E. A. Garcia-Zepeda, Y. C. Lim, M. Yoshida, H. A. Ding, M. A. Jr. Gimbrone, A. D. Luster, F. W. Luscinskas, and A. Rosenzweig. 1999. MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions. Nature 398, 718-723. https://doi.org/10.1038/19546
  14. Imai, T., T. Fujita, and Y. Yamazaki. 2003. Beneficial effects of apolipoprotein A-I on endotoxemia. Surg. Today 33, 684-687. https://doi.org/10.1007/s00595-003-2585-4
  15. Ji, Y., B. Jian, N. Wang, Y. Sun, M. L. Moya, M. C. Phillips, G. H. Rothblat, J. B. Swaney, and A. R. Tall. 1997. Scavenger receptor BI promotes high density lipoprotein-mediated cellular cholesterol efflux. J. Biol. Chem. 272, 20982-20985. https://doi.org/10.1074/jbc.272.34.20982
  16. Kennedy, A. D. and F. R. DeLeo. 2009. Neutrophil apoptosis and the resolution of infection. Immunol. Res. 43, 25-61. https://doi.org/10.1007/s12026-008-8049-6
  17. Kettritz, R., M. L. Gaido, H. Haller, F. C. Luft, C. J. Jennette, and R. J. Falk. 1998. Interleukin-8 delays spontaneous and tumor necrosis factor-${\alpha}$-mediated apoptosis of human neutrophils. Kidney Int. 53, 84-91. https://doi.org/10.1046/j.1523-1755.1998.00741.x
  18. Kim, J. Y., D. H. Lee, J. K. Joo, J. O. Jin, J. W. Wang, Y. S. Hong, J. Y. Kwak, and K. S. Lee. 2009. Effects of peritoneal fluid from endometriosis patients on interferon-gamma-induced protein-10 (CXCL10) and interleukin-8 (CXCL8) released by neutrophils and CD4+ T cells. Am. J. Reprod. Immunol. 62, 128-138. https://doi.org/10.1111/j.1600-0897.2009.00722.x
  19. Kobayashi, Y. 2008. The role of chemokines in neutrophil biology. Front. Biosci. 13, 2400-2407. https://doi.org/10.2741/2853
  20. Liao, X. L., B. Lou, J. Ma, and M. P. Wu. 2005. Neutrophils activation can be diminished by apolipoprotein A-I. Life Sci. 77, 325-335. https://doi.org/10.1016/j.lfs.2004.10.066
  21. Moulding, D. A., J. A. Quayle, C. A. Hart, and S. W. Edwards. 1998. Mcl-1 expression in human neutrophils: regulation by cytokines and correlation with cell survival. Blood 92, 2495-2502.
  22. Murray, J., J. A. Barbara, S. A. Dunkley, A. F. Lopez, X. Van Ostade, A. M. Condliffe, I. Dransfield, C. Haslett, and E. R. Chilvers. 1997. Regulation of neutrophil apoptosis by tumor necrosis factor-${\alpha}$: requirement for TNFR55 and TNF75 for induction of apoptosis in vitro. Blood 90, 2772-2783.
  23. Nanjee, M. N., J. R. Crouse, J. M. King, R. Hovorka, S. E. Rees, E. R. Carson, J. J. Morgenthaler, P. Lerch, and N. E. Miller. 1996. Effects of intravenous infusion of lipid-free ApoA-I in humans. Arterioscler. Thromb. Vasc. Biol. 16, 1203-1214. https://doi.org/10.1161/01.ATV.16.9.1203
  24. Nissen, S. E., T. Tsunoda, E. M. Tuzcu, P. Schoenhagen, C. J. Cooper, M. Yasin, G. M. Eaton, M. A. Lauer, W. S. Sheldon, C. L. Grines, S. Halpern, T. Crowe, J. C. Blankenship, and R. Kerensky. 2003. Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial. JAMA. 290, 2292-2300. https://doi.org/10.1001/jama.290.17.2292
  25. Ohta, K., K. Iwai, Y. Kasahara, N. Taniguchi, S. Krajewski, J. C. Reed, and T. Miyawaki. 1995. Immunoblot analysis of cellular expression of Bcl-2 family proteins, Bcl-2, Bax, Bcl-X, and Mcl-1, in human peripheral blood and lymphoid tissues. Int. Immunol. 7, 1817-1825. https://doi.org/10.1093/intimm/7.11.1817
  26. Park, H. Y., M. G. Song., J. S. Lee, J. W. Kim, J. O. Jin, J. I. Park, Y. C. Chang, and J. Y. Kwak. 2007. Apoptosis of human neutrophils induced by protein phosphatase 1/2A inhibition is caspase-independent and serine protease- dependent. J. Cell Physiol. 212, 450-462. https://doi.org/10.1002/jcp.21039
  27. Rabin, R. L., M. K. Park, F. Liao, R. Swofford, D. Stephany, and J. M. Farber. 1999. Chemokine receptor responses on T cells are achieved through regulation of both receptor expression and signaling. J. Immunol. 3840-3850.
  28. Rader, D. J. 2002. High-density lipoproteins and atherosclerosis. Am. J. Cardiol. 90, 62i-70i. https://doi.org/10.1016/S0002-9149(02)02635-8
  29. Rollins, B. J., T. Yoshimura, E. J. Leonard, and J. S. Pober. 1990. Cytokine-activated human endothelial cells synthesize and secrete a monocyte chemoattractant, MCP-1/JE. Am. J. Pathol. 136, 1229-1233.
  30. Santos-Gallego, C. G., B. Ibanez, and J. J. Badimon. 2008. HDL-cholesterol: is it really good? Differences between apoA-I and HDL. Biochem. Pharmacol. 76, 443-452. https://doi.org/10.1016/j.bcp.2008.04.020
  31. Segrest, J. P., D. W. Garber, C. G. Brouillette, S. C. Harvey, and G. M. Anantharamaiah. 1994. The amphipathic ${\alpha}$ helix: a multifunctional structural motif in plasma apolipoproteins. Adv. Protein. Chem. 45, 303-369. https://doi.org/10.1016/S0065-3233(08)60643-9
  32. Segrest, J. P., L. Li, G. M. Anantharamaiah, S. C. Harvey, K. N. Liadaki, and V. Zannis. 2000. Structure and function of apolipoprotein A-I and high-density lipoprotein. Curr. Opin. Lipidol. 11, 105-115. https://doi.org/10.1097/00041433-200004000-00002
  33. Serhan, C. N. and J. Savill. 2005. Resolution of inflammation: the beginning programs the end. Nat. Immunol. 6, 1191-1197. https://doi.org/10.1038/ni1276
  34. Shi, N. and M. P. Wu. 2008. Apolipoprotein A-I attenuates renal ischemia/reperfusion injury in rats. J. Biomed. Sci. 15, 577-583. https://doi.org/10.1007/s11373-008-9258-7
  35. Soehnlein, O. and C. Weber. 2009. Myeloid cells in atherosclerosis: initiators and decision shapers. Semin. Immunopathol. 31, 35-47. https://doi.org/10.1007/s00281-009-0141-z
  36. Taub, D. D., A. R. Lloyd, K. Conlon, J. M. Wang, J. R. Ortaldo, A. Harada, K. Matsushima, D. J. Kelvin, and J. J. Oppenheim. 1993. Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothelial cells. J. Exp. Med. 177, 1809-1814. https://doi.org/10.1084/jem.177.6.1809
  37. Weinberger, J. 2005. Diagnosis and prevention of atherosclerotic cerebral infarction. CNS Spectr. 10, 553-564.
  38. Yang, T., H. L. Buchan, K. J. Townsend, and R. W. Craig. 1996. MCL-1, a member of the BCL-2 family, is induced rapidly in response to signals for cell differentiation or death, but not to signals for cell proliferation. J. Cell Physiol. 166, 523-536. https://doi.org/10.1002/(SICI)1097-4652(199603)166:3<523::AID-JCP7>3.0.CO;2-R
  39. Zernecke, A., I. Bot, Y. Djalali-Talab, E. Shagdarsuren, K. Bidzhekov, S. Meiler, R. Krohn, A. Schober, M. Sperandio, O. Soehnlein, J. Bornemann, F. Tacke, E. A. Biessen, and C. Weber. 2008. Protective role of CXC receptor 4/CXC ligand 12 unveils the importance of neutrophils in atherosclerosis. Circ. Res. 102, 209-217. https://doi.org/10.1161/CIRCRESAHA.107.160697